Woman who developed cancer after using J&J wins $70 Million
Cancer patient who developed disease after using Johnson & Johnson talcum powder wins $70million payout from the company
Deborah Giannecchini claimed baby powder use gave her ovarian cancer
Her lawsuit claimed the company should attach warnings to the product
Mrs Giannecchini used talcum powder in an intimate area for many years
Johnson & Johnson claim their product is safe and will appeal the award
Quote:
A jury has awarded a woman $70million in damages against Johnson & Johnson after the woman claimed talcum powder caused her ovarian cancer.
Deborah Giannecchini of Modesto, California was diagnosed with the disease in 2012 and accused the company of 'negligent conduct' in making and and marketing the baby powder.
The lawsuit claimed Mrs Giannecchini contracted the disease after using baby powder in an intimate area.
http://i.dailymail.co.uk/i/pix/2016/...7658277357.jpg Deborah Giannecchini, pictured, of Modesto, California claimed using Johnson & Johnson's baby powder in an intimate fashion over many years led to her developing ovarian cancer
Quote:
However, the company has rejected there is any risk to using their product - even in intimate areas - and will appeal the massive award.
http://i.dailymail.co.uk/i/pix/2016/...7658256831.jpg Deborah Giannecchini of Modesto, California claimed using Johnson & Johnson's baby powder in an intimate fashion over the course of many years led to her developing ovarian cancer
Quote:
Earlier this year, two other lawsuits in St Louis ended in jury verdicts worth a combined $127million. But two others in New Jersey were thrown out by a judge who said there wasn't reliable evidence that talc leads to ovarian cancer, an often fatal but relatively rare form of cancer.
Ovarian cancer accounts for about 22,000 of the 1.7million new cases of cancer expected to be diagnosed in the US this year.
About 2,000 women have filed similar suits, and lawyers are reviewing thousands of other potential cases, most generated by ads touting the two big verdicts out of St. Louis - a $72million award in February to relatives of an Alabama woman who died of ovarian cancer, and a $55million award in May to a South Dakota survivor of the disease.
